Qiang Li
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 18
- Nephrology top 2%
- Acute Kidney Injury Research 16
- Chronic Kidney Disease and Diabetes 13
-
- Cardiovascular Function and Risk Factors 16
- Acute Myocardial Infarction Research 14
- Cardiac, Anesthesia and Surgical Outcomes 13
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 14
- Physiology top 2%
-
- Cardiac Imaging and Diagnostics 17
- Co-authors
- Qiuhe JiWenying YangJianping WengJianzhong XiaoHaoming TianZhongyan ShanLixiang LinWeiping Jia
- Journals
- New England Journal of Medicine (1 paper)The Lancet (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Qiang Li
303 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Endocrinology, Diabetes and Metabolism 1.7k
- Nephrology 288
- Cardiology and Cardiovascular Medicine 876
- Surgery 1.7k
- Physiology 956
Countries citing papers authored by Qiang Li
This map shows the geographic impact of Qiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Li more than expected).
Fields of papers citing papers by Qiang Li
This network shows the impact of papers produced by Qiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Li. The network helps show where Qiang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qiang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 2 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 63 | |
| 17 | 2015 | 59 | |
| 18 | 2014 | 63 | |
| 19 | 2014 | 21 | |
| 20 | 2011 | 1 |
About Qiang Li
Qiang Li is a scholar working on Nephrology, Surgery and Cardiology and Cardiovascular Medicine, having authored 319 papers that have together received 7.0k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Cardiac Imaging and Diagnostics (17 papers), Acute Kidney Injury Research (16 papers), Cardiovascular Function and Risk Factors (16 papers), Acute Myocardial Infarction Research (14 papers), Bladder and Urothelial Cancer Treatments (14 papers), Cardiac, Anesthesia and Surgical Outcomes (13 papers) and Chronic Kidney Disease and Diabetes (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Nephrology (288 citations) and Cardiology and Cardiovascular Medicine (876 citations). Qiang Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qiuhe Ji, Wenying Yang, Jianping Weng, Jianzhong Xiao, Haoming Tian, Zhongyan Shan, Lixiang Lin, Weiping Jia, Li Chen and Guangliang Shan. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.